{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:21:34Z","timestamp":1778642494718,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016238","name":"Ministerie van Landbouw Natuur en Voedselkwaliteit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tox.2026.154442","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:06:15Z","timestamp":1772816775000},"page":"154442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro inhibition of monoamine transport by amphetamine-like pre-workout supplement ingredients"],"prefix":"10.1016","volume":"523","author":[{"given":"Nicole E.T.","family":"Pinckaers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina D.","family":"Sawicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Pepijn","family":"Wopken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Matthijs","family":"Blankesteijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik-Jan","family":"van Schooten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoon","family":"Opperhuizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2751-8972","authenticated-orcid":false,"given":"Misha","family":"Vrolijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-2007","authenticated-orcid":false,"given":"Remco H.S.","family":"Westerink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tox.2026.154442_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pbb.2011.10.025","article-title":"Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1","volume":"101","author":"Achat-Mendes","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7-8","key":"10.1016\/j.tox.2026.154442_bib2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/dta.1491","article-title":"Analysis of 1,3 dimethylamylamine concentrations in Geraniaceae, geranium oil and dietary supplements","volume":"6","author":"Austin","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.tox.2026.154442_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpba.2019.05.066","article-title":"Liquid chromatography-quadrupole time of flight mass spectrometric method for targeted analysis of 111 nitrogen-based compounds in weight loss and ergogenic supplements","volume":"174","author":"Avula","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.tox.2026.154442_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0304-4165(89)90002-0","article-title":"Characterization of monoamine oxidase activity present in human granulocytes and lymphocytes","volume":"992","author":"Balsa","year":"1989","journal-title":"Biochim. Et. Biophys. Acta (BBA) Gen. Subj."},{"issue":"7291","key":"10.1016\/j.tox.2026.154442_bib5","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bmj.322.7291.912","article-title":"ABC of hypertension: the pathophysiology of hypertension","volume":"322","author":"Beevers","year":"2001","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.tox.2026.154442_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/mp.2008.90","article-title":"Potential adverse effects of amphetamine treatment on brain and behavior: a review","volume":"14","author":"Berman","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.tox.2026.154442_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1080\/19440049.2019.1633020","article-title":"A health risk for consumers: the presence of adulterated food supplements in the Netherlands","volume":"36","author":"Biesterbos","year":"2019","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess."},{"issue":"2","key":"10.1016\/j.tox.2026.154442_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1471-4159.1998.71020653.x","article-title":"Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter","volume":"71","author":"Chen","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2026.154442_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/15563650.2025.2515242","article-title":"Presence and quantity of ingredients in sports supplements purportedly containing the orchid Eria jarensis","author":"Cohen","year":"2025","journal-title":"Clinical Toxicology15"},{"issue":"7","key":"10.1016\/j.tox.2026.154442_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.23879","article-title":"Presence and Quantity of Botanical Ingredients With Purported Performance-Enhancing Properties in Sports Supplements","volume":"6","author":"Cohen","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"3-4","key":"10.1016\/j.tox.2026.154442_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/dta.1793","article-title":"An amphetamine isomer whose efficacy and safety in humans has never been studied, \u03b2-methylphenylethylamine (BMPEA), is found in multiple dietary supplements","volume":"8","author":"Cohen","year":"2016","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.tox.2026.154442_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/15563650.2018.1497171","article-title":"The stimulant higenamine in weight loss and sports supplements","volume":"57","author":"Cohen","year":"2019","journal-title":"Clin. Toxicol. (Philos. )"},{"issue":"6","key":"10.1016\/j.tox.2026.154442_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/15563650.2017.1398328","article-title":"Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA)","volume":"56","author":"Cohen","year":"2018","journal-title":"Clin. Toxicol. (Philos. )"},{"key":"10.1016\/j.tox.2026.154442_bib14","author":"Cohen","year":"2021","journal-title":"Taylor Fr. Ltd"},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/dta.1735","article-title":"A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements","volume":"7","author":"Cohen","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.tox.2026.154442_bib16","first-page":"879","article-title":"Hemorrhagic Stroke Probably Caused by Exercise Combined With a Sports Supplement Containing \u03b2-Methylphenyl-ethylamine (BMPEA): A Case Report","volume":"162","author":"Cohen","year":"2015","journal-title":"Am. Coll. Physicians"},{"key":"10.1016\/j.tox.2026.154442_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yrtph.2018.06.014","article-title":"Drug adulteration of food supplements: A threat to public health in the European Union?","volume":"97","author":"Czepielewska","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12012-022-09777-z","article-title":"Review of Case Reports on Adverse Events Related to Pre-workout Supplements Containing Synephrine","volume":"23","author":"de Jonge","year":"2023","journal-title":"Cardiovasc Toxicol."},{"issue":"S2","key":"10.1016\/j.tox.2026.154442_bib19","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/jcph.1918","article-title":"Pharmacology of drugs used as stimulants","volume":"61","author":"Docherty","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2026.154442_bib20","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fpsyg.2018.01134","article-title":"Boost Me: Prevalence and Reasons for the Use of Stimulant Containing Pre Workout Supplements Among Fitness Studio Visitors in Mainz (Germany)","volume":"9","author":"Dreher","year":"2018","journal-title":"Front Psychol."},{"issue":"12","key":"10.1016\/j.tox.2026.154442_bib21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.7205\/MILMED-D-12-00265","article-title":"Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA)","volume":"177","author":"Eliason","year":"2012","journal-title":"Mil. Med"},{"key":"10.1016\/j.tox.2026.154442_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New Insights into the Mechanism of Action of Amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.tox.2026.154442_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.annemergmed.2012.04.008","article-title":"Use of Recreational Drug 1,3-Dimethylethylamine (DMAA) Associated With Cerebral Hemorrhage","volume":"60","author":"Gee","year":"2012","journal-title":"Ann. Emerg. Med."},{"issue":"16","key":"10.1016\/j.tox.2026.154442_bib24","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMsa1504267","article-title":"Emergency Department Visits for Adverse Events Related to Dietary Supplements","volume":"373","author":"Geller","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.tox.2026.154442_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharm."},{"issue":"9","key":"10.1016\/j.tox.2026.154442_bib26","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/npp.2015.61","article-title":"Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits","volume":"40","author":"Harkness","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"9-10","key":"10.1016\/j.tox.2026.154442_bib27","doi-asserted-by":"crossref","first-page":"e2030","DOI":"10.7205\/MILMED-D-17-00013","article-title":"Hemorrhagic Stroke in a Young Healthy Male Following Use of Pre-Workout Supplement Animal Rage XL","volume":"182","author":"Harris","year":"2017","journal-title":"Mil. Med."},{"key":"10.1016\/j.tox.2026.154442_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuint.2018.08.015","article-title":"Model systems for analysis of dopamine transporter function and regulation","volume":"123","author":"Hovde","year":"2019","journal-title":"Neurochem. Int"},{"issue":"5","key":"10.1016\/j.tox.2026.154442_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2125.2003.01922.x","article-title":"An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B\/1D agonist, as a model drug","volume":"56","author":"Iwasa","year":"2003","journal-title":"Br. J. Clin. Pharm."},{"issue":"9","key":"10.1016\/j.tox.2026.154442_bib30","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1073\/pnas.0407737102","article-title":"Amphetamine induces dopamine efflux through a dopamine transporter channel","volume":"102","author":"Kahlig","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46627-5","article-title":"Differential mechanisms of action of the trace amines octopamine, synephrine and tyramine on the porcine coronary and mesenteric artery","volume":"9","author":"Koh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2026.154442_bib32","article-title":"Renal artery responses to trace amines: Multiple and differential mechanisms of action","volume":"277","author":"Koh","year":"2021","journal-title":"Elsevier Inc."},{"key":"10.1016\/j.tox.2026.154442_bib33","doi-asserted-by":"crossref","first-page":"w14043","DOI":"10.4414\/smw.2015.14043","article-title":"Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling","author":"Liechti","year":"2015","journal-title":"Swiss Med. Wkly 145"},{"issue":"11","key":"10.1016\/j.tox.2026.154442_bib34","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1007\/s00213-022-06246-x","article-title":"Reinforcing effects of phenethylamine analogs found in dietary supplements","volume":"239","author":"McGriff","year":"2022","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.tox.2026.154442_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bcpt.13912","article-title":"Serotonin syndrome\u2014A focused review","volume":"133","author":"Mikkelsen","year":"2023","journal-title":"Basic & Clin. Pharmacol. & Toxicol."},{"key":"10.1016\/j.tox.2026.154442_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuro.2017.09.006","article-title":"Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity","volume":"63","author":"Miner","year":"2017","journal-title":"NeuroToxicology"},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41598-021-03885-6","article-title":"Phenethylamine is a substrate of monoamine oxidase B in the paraventricular thalamic nucleus","volume":"12","author":"Obata","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib38","first-page":"7","article-title":"Studies on beta-phenylethylamine deamination by human placental monoamine oxidase. Jpn J Pharmacol","volume":"31","author":"Oguchi","year":"1981"},{"issue":"9","key":"10.1016\/j.tox.2026.154442_bib39","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/dta.2871","article-title":"Analysis of bitter orange dietary supplements for natural and synthetic phenethylamines by LC-MS\/MS","volume":"12","author":"Pawar","year":"2020","journal-title":"Drug Test. Anal."},{"issue":"5","key":"10.1016\/j.tox.2026.154442_bib40","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00204-025-03992-7","article-title":"Quantitative in vitro-to-in vivo extrapolation of human adrenergic and trace amine-associated receptor 1 potencies of pre-workout supplement ingredients using physiologically based kinetic modelling-based reverse dosimetry","volume":"99","author":"Pinckaers","year":"2025","journal-title":"Arch. Toxicol."},{"issue":"11","key":"10.1016\/j.tox.2026.154442_bib41","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/nu16111567","article-title":"Vitro Activation of Human Adrenergic Receptors and Trace Amine-Associated Receptor 1 by Phenethylamine Analogues Present in Food Supplements","volume":"16","author":"Pinckaers","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.tox.2026.154442_bib42","unstructured":"Razenberg L., Notenboom, S., De Wit-Bos, L. (2021) Het gebruik van workoutsupplementen door sporters in Nederland. Rijksinstituur voor Volksgezondheid en Milieu (RIVM)."},{"key":"10.1016\/j.tox.2026.154442_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172515","article-title":"Pharmacological profiles of compounds in preworkout supplements (\"boosters\")","volume":"859","author":"Rickli","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.tox.2026.154442_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.118.255976","article-title":"The supplement adulterant b-methylphenethylamine increases blood pressure by acting at peripheral norepinephrine transporters","volume":"369","author":"Schindler","year":"2019","journal-title":"Am. Soc. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib45","first-page":"17","article-title":"The crosstalk between autonomic nervous system and blood vessels","volume":"10","author":"Sheng","year":"2018","journal-title":"Int J. Physiol. Pathophysiol. Pharm."},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.tox.2026.154442_bib47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.122.001573","article-title":"The Alkylamine Stimulant 1,3-Dimethylamylamine Exhibits Substrate-Like Regulation of Dopamine Transporter Function and Localization","volume":"386","author":"Small","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2026.154442_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.14503\/THIJ-12-2870","article-title":"Acute myocardial infarction associated with dietary supplements: Containing 1,3-dimethylamylamine and Citrus aurantium","volume":"41","author":"Smith","year":"2014","journal-title":"Tex. Heart Inst."},{"issue":"5","key":"10.1016\/j.tox.2026.154442_bib49","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","article-title":"Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport","volume":"15","author":"Sulzer","year":"1995","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.tox.2026.154442_bib50","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/BF01963957","article-title":"Oxidation of synephrine by type A and type B monoamine oxidase","volume":"35","author":"Suzuki","year":"1979","journal-title":"Experientia"},{"issue":"4","key":"10.1016\/j.tox.2026.154442_bib51","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41380-019-0469-2","article-title":"Amphetamines signal through intracellular TAAR1 receptors coupled to G\u03b1(13) and G\u03b1(S) in discrete subcellular domains","volume":"26","author":"Underhill","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0024-3205(98)00535-9","article-title":"Caco-2 cells in culture synthesize and degrade dopamine and 5-hydroxytryptamine: a comparison with rat jejunal epithelial cells","volume":"64","author":"Vieira-Coelho","year":"1999","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.tox.2026.154442_bib53","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archneur.64.11.1575","article-title":"Dopamine in Drug Abuse and Addiction: Results of Imaging Studies and Treatment Implications","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.tox.2026.154442_bib54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00018-012-1065-7","article-title":"Monoamine oxidases in development","volume":"70","author":"Wang","year":"2013","journal-title":"Cell Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.tox.2026.154442_bib55","first-page":"9","article-title":"Het gebruik van voedingssupplementen en sportvoeding door meer en minder actieve Nederlanders \u2013 Een inventarisatie op basis van het Nationaal Sport Onderzoek 2012 onder de Nederlandse bevolking","volume":"69","author":"Wardenaar","year":"2014","journal-title":"Ned. Tijdschr. Voor Voeding En. Dietiek"},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib56","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.109.153775","article-title":"A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain","volume":"330","author":"Xie","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.tox.2026.154442_bib57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1124\/jpet.107.135079","article-title":"Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes","volume":"325","author":"Xie","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.tox.2026.154442_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-021-03223-9","article-title":"Sports nutrition supplements and adverse events - a meta-epidemiological study of case reports specifically addressing causality assessment","volume":"78","author":"Zeijlon","year":"2022","journal-title":"Eur. J. Clin. Pharm."},{"issue":"12","key":"10.1016\/j.tox.2026.154442_bib59","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/dta.1368","article-title":"1,3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic?","volume":"4","author":"Zhang","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.tox.2026.154442_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpba.2018.01.025","article-title":"Detection and quantification of phenethylamines in sports dietary supplements by NMR approach","volume":"151","author":"Zhao","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.tox.2026.154442_bib61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/cbdd.12192","article-title":"Combining Structure-Based Pharmacophore and In Silico Approaches to Discover Novel Selective Serotonin Reuptake Inhibitors","volume":"82","author":"Zhou","year":"2013","journal-title":"Chem. Biol. & Drug Des."},{"key":"10.1016\/j.tox.2026.154442_bib62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tiv.2017.05.010","article-title":"Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay","volume":"45","author":"Zwartsen","year":"2017","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2026.154442_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104631","article-title":"Corrigendum to \u201cMeasuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay\u201d [Toxicology in Vitro (2017) 60\u201371]","volume":"62","author":"Zwartsen","year":"2020","journal-title":"Toxicol. Vitr."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X26000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X26000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:42:58Z","timestamp":1774960978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X26000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":63,"alternative-id":["S0300483X26000491"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2026.154442","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro inhibition of monoamine transport by amphetamine-like pre-workout supplement ingredients","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2026.154442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154442"}}